PureHelix™ Genomic Prep Kit [Bacteria] (Solution based)
- Known as:
- PureHelix™ Genomic Prep Kit [Bacteria] (Solution based)
- Catalog number:
- GSBA100
- Product Quantity:
- 100 preps/kit
- Category:
- -
- Supplier:
- NanoHelix
- Gene target:
- PureHelix™ Genomic Prep Kit [Bacteria] (Solution based)
Related genes to: PureHelix™ Genomic Prep Kit [Bacteria] (Solution based)
- Gene:
- PREP NIH gene
- Name:
- prolyl endopeptidase
- Previous symbol:
- -
- Synonyms:
- -
- Chromosome:
- 6q21
- Locus Type:
- gene with protein product
- Date approved:
- 1996-03-12
- Date modifiied:
- 2016-10-05
Related products to: PureHelix™ Genomic Prep Kit [Bacteria] (Solution based)
Human ELC ELISA KIT 96 TEST
OxiSelect In Vitro ROS/RNS Assay Kit (Green Fluorescence), Trial Size
OxiSelect Methylglyoxal (MG) Competitive ELISA Kit
OxiSelect Methylglyoxal (MG) Competitive ELISA Kit
OxiSelect TBARS Assay Kit (MDA Quantitation), Trial Size
OxiSelect Total Antioxidant Capacity (TAC) Assay Kit, Trial Size
OxiSelect™ In Vitro ROS RNS Assay Kit (Green Fluorescence), Trial Size(+)_1_(9_Fluorenyl)ethyl chloroformate 0.5 w_v% solution in ac(1-Kit )11,12-EET DHET Immunoassay Kit(1-Kit )11,12-EET_DHET Immunoassay Kit(1-Kit) 11,12-DHET Immunoassay Kit(1-Kit) 14,15-DHET Human Urine ELISA Kit(1-Kit) 14,15-DHET Hypertension ELISA Kit(1-Kit) 14,15-DHET sEH activity ELISA Kit(1-Kit) 14,15-EET DHET Hypertension ELISA Kit Related articles to: PureHelix™ Genomic Prep Kit [Bacteria] (Solution based)
- Oral Pre-Exposure Prophylaxis (PrEP) is highly effective for HIV prevention when adherence is optimal, with rare HIV breakthrough infections usually happening within 1-2 years since PrEP start. After 6 years of daily PrEP, routine HIV testing identified seroconversion in a 46-year-old Italian cisgender man. He reported high adherence, confirmed by pharmacy refill history and plasma tenofovir concentration. Genotypic resistance test identified a recombinant HIV-1 strain with M184V and K70E reverse transcriptase mutations. Immediate antiretroviral therapy with FTC/TAF/DRV/c+DTG was initiated, achieving rapid viral suppression. A hair sample was sent for therapeutic drug monitoring and results were consistent with correct daily tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) before the acquisition of HIV infection. This case represents a rare PrEP failure after the longest reported duration of daily TDF/FTC PrEP with confirmed optimal adherence. It highlights that breakthrough HIV infection can occur even after many years of successful PrEP use, underlying the importance of periodic HIV surveillance. - Source: PubMed
Publication date: 2026/10/07
Bana Nicholas BrianMoschese DavideRezzonico Leonardo FrancescoCaruso EnricoMuccini CamillaBurastero Giulia JoleDe Bona AnnaFrattini NicolettaD'Amico FedericoCernuschi MassimoSimoncini ElenaPuoti MassimoRossotti Roberto - Sex workers on HIV pre-exposure prophylaxis (PrEP) experience high bacterial sexually transmitted infection (STI) rates. We assessed associations between gender identity and first/recurrent STI incidence to inform risk-stratified screening. - Source: PubMed
Publication date: 2026/10/07
Valencia JorgeMatarranz MarianoGuillamet Laia J VázquezCuevas GuillermoTroya JesúsPárbole PedroArroyo DavidManzano SamuelPérez-García FelipeRyan PabloResino Salvador - Cisgender women, particularly Black women in the Southeastern U.S., experience substantial HIV risk. While current prevention strategies emphasize individual-level risk indicators, understanding the relative contributions of structural determinants and psychosocial factors is essential. This study aimed to evaluate the effects of structural determinants, psychosocial factors, and individual indicators on HIV risk among women in a high-incidence U.S. region. - Source: PubMed
Publication date: 2026/10/08
LeCates AbigailSchwinne MeganYang MingyaAssi MariamRobichaux ChadHollenberg EmmaSheth Anandi NGruber SarahLora Meredith - People who inject drugs (PWID) in the Southern United States face elevated HIV risk due to limited testing, constrained PrEP access and structural barriers to harm reduction. Within syringe service programs (SSPs), universal PrEP delivery may be inefficient. Key subgroups - individuals engaged in sex work, men who have sex with men (MSM) and people sharing syringes - have distinct risk profiles, awareness, and motivation that influence PrEP uptake. This study identifies high-yield groups for risk-stratified PrEP delivery in SSPs. We conducted a cross-sectional survey of 685 PWID attending SSPs in Tennessee. Measures included demographics, drug use, sexual risk, PrEP awareness, willingness to initiate PrEP and objective HIV risk using the ARCH tool. Multivariate logistic regression identified predictors of willingness. Overall, 63.1% reported willingness to use PrEP. Willingness was highest among those engaged in sex work (80-81%; adjusted OR 2.5-3.3, < 0.05). MSM had greater awareness but no higher adjusted willingness. Syringe sharers had the highest objective risk yet lower awareness and willingness, indicating a high-risk but harder-to-engage group. These findings highlight the potential value of tailoring PrEP promotion strategies within SSPs. While individuals engaged in sex work may be well positioned for rapid PrEP initiation, additional efforts may be needed to improve PrEP uptake among those who report syringe sharing. - Source: PubMed
Publication date: 2026/10/07
Edgerton RyanChandler CristianWilhelm AllisonPettit AprilAudet CarolynRebeiro PeterGinn LorenPichon LatriceHaq RabeeRodney JohnCooper Robert Lyle - Digital health interventions (DHIs) for HIV prevention have demonstrated feasibility, acceptability, and, to a lesser extent, efficacy, but few have achieved widespread dissemination. We used intervention mapping and single-session design principles to adapt Keep It Up! (KIU!), a CDC-designated best-evidence HIV prevention program originally delivered over 6 months, into a single-session intervention, Keep It Brief! A 13-member expert and community advisory board guided six adaptation steps, prioritizing behavioral outcomes, objectives, and KIU!'s core theoretical determinants. The resulting intervention includes a universal HIV module, a tailored PrEP module based on users' PrEP experience, and a relationship module for participants who are single, monogamous, or in open/polyamorous relationships. Usability testing with 15 end users demonstrated high acceptability, engagement, and usability. Findings suggest that adapting multisession DHIs into single-session formats can preserve core intervention mechanisms while improving reach to populations and settings where multisession delivery is infeasible. We provide recommendations for future adaptation. - Source: PubMed
Zapata Juan PabloGorkin Alyssa NLiao JessicaZamantakis AlithiaSaber RanaSchleider Jessica LeeMustanski Brian